Fitness-to-drive

The management of brain tumour patients who would like to resume driving is complex, and needs multidisciplinary input and a consensus among treating physicians. The Swiss Neuro-Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM) aim to provide guidance on how to assess fitness-to-drive; of glioblastoma patients and to harmonise the relevant procedures in Switzerland.

At several meetings, Swiss neuro-oncologists discussed common practices on how to advise patients with a stable, i.e., non-progressive, glioblastoma, who wish to resume driving after the initial standard tumour treatment. All participants of the SwissNOS meetings were invited twice to return a questionnaire (modified Delphi process) on specific tools/procedures they commonly use to assess fitness-to-drive; of their patients. Answers were analysed to formulate a tentative consensus for a structured and reasonable approach.

Consensus on minimum requirements for a fitness-to-drive programme for glioblastoma patients could be reached among Swiss neuro-oncologists. The recommendations were based on existing guidelines and expert opinions regarding patients with seizures, visual disturbances, cognitive impairment or focal deficits for safe driving. At this point in time, the Swiss neuro-oncologists agreed on the following requirements for glioblastoma patients after the initial standard therapy and without a seizure for at least12 months: (1) stable cranial magnetic resonance imaging (MRI) according to Response Assessment in Neuro-Oncology (RANO) criteria, to be repeated every 3 months; (2) thorough medical history, including current or new medication, a comprehensive neurological examination at baseline (T0) and every 3 months thereafter, optionally an electrocencephalogram (EEG) at baseline; (3) ophthalmological examination including visual acuity and intact visual fields; and (4) optional neuropsychological assessment with a focus on safe driving. Test results have to be compatible with safe driving at any time-point. Patients should be informed about test results and optionally sign a document.

They proposed regular thorough clinical neurological examination and brain MRI, optional EEG, neuropsychological and visual assessments to confirm fitness-to-drive for glioblastoma patients after initial tumour-directed therapy. The proposed fitness-to-drive assessments for glioblastoma patients serves as the basis for a prospective Swiss Pilot Project GLIODRIVE (BASEC ProjectID 2020-00365) to test feasibility, adherence and safety in a structured manner for patients who wish to resume driving. Research will focus on confirming the usefulness of the proposed tools in predicting fitness-to-drive and match results with events obtained from the road traffic registry (Strassenverkehrsamt) 1).

2: Sawada T, Tomori K, Hamana H, Ohno K, Seike Y, Igari Y, Fujita Y. Reliability and validity of on-road driving tests in vulnerable adults: a systematic review. Int J Rehabil Res. 2019 Dec;42(4):289-299. doi: 10.1097/MRR.0000000000000374. PMID: 31469673; PMCID: PMC7597760.

3: Moses MJ, Tishelman JC, Hasan S, Zhou PL, Zevgaras I, Smith JS, Buckland AJ, Kim Y, Razi A, Protopsaltis TS. Lack of Consensus in Physician Recommendations Regarding Return to Driving After Cervical Spine Surgery. Spine (Phila Pa 1976). 2018 Oct 15;43(20):1411-1417. doi: 10.1097/BRS.0000000000002625. PMID: 29528997.

4: Makarenko S, Ye V, Gooderham PA, Akagami R. A novel scale for describing visual outcomes in patients following resection of lesions affecting the optic apparatus: the Unified Visual Function Scale. J Neurosurg. 2018 Dec 1;129(6):1438-1445. doi: 10.3171/2017.6.JNS17707. PMID: 29327998.

5: Mansur A, Desimone A, Vaughan S, Schweizer TA, Das S. To drive or not to drive, that is still the question: current challenges in driving recommendations for patients with brain tumours. J Neurooncol. 2018 Apr;137(2):379-385. doi: 10.1007/s11060-017-2727-y. Epub 2018 Jan 2. PMID: 29294231.

6: Hird MA, Vetivelu A, Saposnik G, Schweizer TA. Cognitive, on-road, and simulator-based driving assessment after stroke. J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2654-2670. doi: 10.1016/j.jstrokecerebrovasdis.2014.06.010. Epub 2014 Oct 11. PMID: 25306401.

7: Marshall S, Demmings EM, Woolnough A, Salim D, Man-Son-Hing M. Determining fitness to drive in older persons: a survey of medical and surgical specialists. Can Geriatr J. 2012 Dec;15(4):101-19. doi: 10.5770/cgj.15.30. Epub 2012 Dec 4. PMID: 23259024; PMCID: PMC3516354.

8: Small JM. Craniotomy and fitness to drive. Lancet. 1979 Sep 8;2(8141):527. doi: 10.1016/s0140-6736(79)91582-4. PMID: 90243.

9: Williams B. Craniotomy and fitness to drive. Lancet. 1979 Aug 11;2(8137):300-1. doi: 10.1016/s0140-6736(79)90309-x. PMID: 88624.


1)
Hofer S, Keller K, Imbach L, Roelcke U, Hutter G, Thomas H, Hertler C, Le Rhun E, Vasella F, Cordier D, Neidert M, Hottinger A, Migliorini D, Pflugshaupt T, Eggenberger N, Baumert B, Läubli H, Gramatzki D, Reinert M, Pesce G, Schucht P, Frank I, Lehnick D, Weiss T, Hans-Georg W, Wolpert F, Roth P, Weller M. Fitness-to-drive for glioblastoma patients: Guidance from the Swiss Neuro- Oncology Society (SwissNOS) and the Swiss Society for Legal Medicine (SGRM). Swiss Med Wkly. 2021 May 16;151:w20501. doi: 10.4414/smw.2021.20501. PMID: 34000060.
  • fitness-to-drive.txt
  • Last modified: 2024/06/07 02:59
  • by 127.0.0.1